FDA Probes Generic Antidepressant Wellbutrin XL After Complaints

October 26, 2007 (FinancialWire) The U.S. Food and Drug Administration is investigating complaints about a generic version of the antidepressant drug Wellbutrin XL after users reported having headaches, anxiety and other ailments.